“Efficacy and safety of secukinumab in the treatment of chronic plaque psoriasis: A 52-weeks follow up study” (2024) Journal of Pakistan Association of Dermatologists, 34(1), pp. 191–199. doi:10.66344/jpad.v34i1.2545.